Tuesday, July 1, 2025 7/1/2025

Joint Estimate Diffusion Imaging (JEDI) for improved Tissue Characterization and Neural Connectivity in Aging and Alzheimer's Disease

Award Number: R01AG079280
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 06/01/2023
PERIOD OF PERFORMANCE END DATE: 02/29/2028

Group Awards By:

View Award Description

Joint Estimate Diffusion Imaging (JEDI) for improved Tissue Characterization and Neural Connectivity in Aging and Alzheimer's Disease - Alzheimer's Disease (AD) and related dementias (ADRD) are characterized by progressive structural changes of brain tissue that results in a debilitating loss of cognitive and functional abilities and has profound social and economic implications. While hallmark AD pathology (e.g. beta amyloid depositions and neuroﬁbrillary tangles) are remarkably pronounced at the cellular level, there are currently no successful non- invasive brain imaging techniques to report these microstructural changes. Diffusion magnetic resonance imaging (dMRI) is a widely available non-invasive clinical imaging method with this potential, as it is sensitive to the subtle motion of water within the complex brain gray matter (GM) and white matter (WM) tissue architecture. In principle, dMRI can report both the local tissue structure and the long range connectivity of neural tracts in order to identify pathology and determine the effects of AD on functional brain networks. Unfortunately, the clinical utility of the standard dMRI methodology is severely compromised by its lack of speciﬁcity to microstructural tissue changes below the image resolution. Recently, however, we have developed a novel acquisition and analysis method called Joint Estimation Diffusion Imaging (JEDI) that is highly sensitive to microstructural features of GM and GM/WM border regions, and also provides improved connectivity maps from WM. JEDI is easily implemented on a clinical scanner and we have recently incorporated it into a ﬁrst study on subjects ranging from cognitively normal (CN) to Mild Cognitive Impairment (MCI) to early AD in order to assess its ability to detect changes in these groups. Two critical steps in extending the clinical utility of JEDI in AD are: 1) To characterize the relationship between the JEDI data and speciﬁc tissue microstructural features in order to develop quantitative clinical metrics and 2) To develop efﬁcient acquisition protocols for both microstructural sensitivity and limited patient scan time. That is the focus of this proposal, which will involve three lines of work: 1) Numerical computer simulations of the JEDI experiment in realistic tissue models that will allow us to efﬁciently optimize the acquisition protocol for maximum speciﬁcity and minimal time; 2) Validate these optimizations through in-vivo evaluation of normal aging processes in the ferret and in ex-vivo radiologic-pathologic analysis in post-mortem human tissue from patients with different stages of AD; 3) Incorporate these optimizations into the JEDI acquisition and analysis of human protocols on our clinical scanners with speciﬁc application to examining the prodromal microstructure tissue changes across the aging-MCI-AD continuum. By enabling a reliable, validated and clinically viable method for the quantitative characterization of subtle brain tissue changes across the aging-MCI-AD continuum, JEDI will signiﬁcantly enhance our ability to understand the earliest neurodegenerative features of AD and provide new insights into its causes, consequences, and possible treatment targets.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $1,536,095 )
2025	2025	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Aging Research	000	3	3/14/2025	NON-COMPETING CONTINUATION	$1,410,701
2025	2025	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Aging Research	001	3	6/18/2025	NON-COMPETING CONTINUATION	$125,394
														Subtotal = $1,536,095

Issue Date FY: 2024 ( Subtotal = $1,581,696 )
2024	2024	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Aging Research	000	2	2/12/2024	NON-COMPETING CONTINUATION	$1,423,528
2024	2024	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Aging Research	001	2	7/3/2024	NON-COMPETING CONTINUATION	$158,168
														Subtotal = $1,581,696

Issue Date FY: 2023 ( Subtotal = $1,415,787 )
2023	2023	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DRIVE	LA JOLLA	CA	92093	SAN DIEGO	USA	Aging Research	000	1	5/18/2023	NEW	$1,415,787
														Subtotal = $1,415,787

Grand Total All Awards = $4,533,578

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Joint Estimate Diffusion Imaging (JEDI) for improved Tissue Characterization and Neural Connectivity in Aging and Alzheimer's Disease

Award Number: R01AG079280

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 06/01/2023

PERIOD OF PERFORMANCE END DATE: 02/29/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer